Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China · Delayed Price · Currency is CNY 9.86
-0.11 (-1.10%)
Aug 11, 2026, 3:04 PM CST
SHE:301060 Market Cap
SHE:301060 has a market cap or net worth of 3.97 billion as of August 11, 2026. Its market cap has decreased by -6.91% in one year.
Market Cap
3.97B
Enterprise Value
3.38B
Revenue
1.38B
Ranking
n/a
PE Ratio
270.01
Stock Price
9.86
ChartMarket Cap Chart
Since September 13, 2021, SHE:301060's market cap has decreased from 7.32B to 3.97B, a decrease of -45.70%. That is a compound annual growth rate of -11.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 3.97B | 7.78% |
| Dec 31, 2025 | 3.69B | 1.45% |
| Dec 31, 2024 | 3.63B | -31.73% |
| Dec 29, 2023 | 5.32B | -32.23% |
| Dec 30, 2022 | 7.85B | -43.54% |
| Dec 31, 2021 | 13.91B | 90.09% |
| Sep 13, 2021 | 7.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.87B |
| Shanghai Runda Medical Technology | 6.36B |
| Maccura Biotechnology Co.Ltd | 5.65B |
| Cowealth Medical China | 4.93B |
| Thalys Medical Technology Group | 3.85B |
| SMO ClinPlus CO.,LTD. | 3.73B |
| Guangdong Hybribio Biotech | 3.67B |